Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 104.18

+0.1%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (962)	4/12/1999 11:28:00 AM
From: LLCF	Read Replies (1) of 3202

Then there's this from Bloomberg news: "Glaxo Wellcome Plc, novartis AG, SmithKline Beecham Plc and other top drugmakers are poised to announce a collaboration aimed at mapping variations in human genes as the industry's giants try to find new drugs without paying millions of dollars to small biotechnology companies." The project pits the group against companies such as Genset SA and Incyte Pharmaceuticals Inc. which have made a business of mapping genes for a price. blah blah, Perkin-Elmer, blah, blah While some analysts question how well a massive collaboration of rivals in the $300 Billion industry could work, the prospect of such companies joining forces highlights their thirst for genetic information and their desire to cut costs .... blah, blah..... DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next